Teva Pharmaceutical Industries TEVA
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$4.39B-1.9% YoY
Operating profit$1.14B+5.7% YoY
Net profit$234.00M-46.1% YoY
Diluted EPS$0.20-45.9% YoY
Free cash flow$75.00M-66.1% YoY
Operating cash flow$241.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin53.5%
Operating margin19.2%
Net margin2.9%
Return on equity6.6%
Return on assets1.3%
Return on invested capital4.7%
Current ratio0.95
Liabilities / assets80.1%
Cash & investments$4.09B
Total debt$16.98B
Net cash (debt)-$12.90B
Free cash flow / sales3.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-21 16:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $17.26B | Annual | 2025-12-31 | 2026-02-03 |
| Net income | $1.41B | Annual | 2025-12-31 | 2026-02-03 |
| Operating cash flow | $1.65B | Annual | 2025-12-31 | 2026-02-03 |
| Total assets | $40.75B | Period end | 2025-12-31 | 2026-02-03 |
| Total liabilities | $32.83B | Period end | 2025-12-31 | 2026-02-03 |
| Stockholders’ equity | $7.91B | Period end | 2025-12-31 | 2026-02-03 |
| Cash and cash equivalents | $3.56B | Period end | 2025-12-31 | 2026-02-03 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $4.40B | $4.14B | $3.98B | $17.26B | $4.71B |
| Total Operating Revenue | $4.39B | $4.14B | $3.98B | $17.26B | $4.71B |
| Cost of Revenue | $1.96B | $1.99B | $2.01B | $8.32B | $2.06B |
| Gross Profit | $2.44B | $2.15B | $1.97B | $8.94B | $2.66B |
| Operating Expense | $1.30B | $2.00B | $1.21B | $4.99B | $1.39B |
| Selling and Admin Expenses | $1.01B | $1.03B | $1.00B | $3.97B | $1.12B |
| -Selling & Marketing Expense | $709.00M | $717.00M | $696.00M | $2.69B | $753.00M |
| -General & Admin Expense | $298.00M | $317.00M | $304.00M | $1.29B | $367.00M |
| Research & Development | $297.00M | $970.00M | $222.00M | $1.01B | $267.00M |
| Operating Profit | $1.14B | $149.00M | $759.00M | $3.95B | $1.27B |
| Net Non-Operating Interest Income (Expense) | -$190.00M | -$224.00M | -$216.00M | -$985.00M | -$271.00M |
| Non-Operating Interest Expense | $174.00M | $195.00M | $201.00M | $916.00M | $292.00M |
| Total Other Finance Costs | $16.00M | $29.00M | $15.00M | $69.00M | -$21.00M |
| Other Income (Expense) | -$646.00M | -$379.00M | -$107.00M | -$1.74B | -$916.00M |
| Special Income (Charges) | -$714.00M | -$398.00M | -$111.00M | -$1.79B | -$985.00M |
| -Less:Restructuring and Mergern & Acquisition | $60.00M | $55.00M | $30.00M | $279.00M | $37.00M |
| -Less:Impairment of Capital Assets | $228.00M | $113.00M | $9.00M | $1.03B | $773.00M |
| -Less:Other Special Charges | $426.00M | $230.00M | $72.00M | $467.00M | $155.00M |
| Other Non-Operating Income (Expenses) | $68.00M | $19.00M | $4.00M | $1.00M | $18.00M |
| Pretax Profit | $300.00M | -$455.00M | $437.00M | $1.22B | $80.00M |
| Tax | $66.00M | $121.00M | $67.00M | -$180.00M | -$390.00M |
| Net Profit | $234.00M | -$575.00M | $369.00M | $1.42B | $481.00M |
| Profit from Continuing Operations | $234.00M | -$576.00M | $369.00M | $1.42B | $481.00M |
| Minority Interests | $1.00M | – | – | $7.00M | $0.00 |
| Net Income to Parent Company | $233.00M | -$576.00M | $369.00M | $1.41B | $480.00M |
| Net Income to Common Stockholders | $233.00M | -$576.00M | $369.00M | $1.41B | $480.00M |
| Basic EPS | $0.20 | -$0.49 | $0.32 | $1.23 | $0.42 |
| Diluted EPS | $0.20 | -$0.49 | $0.31 | $1.21 | $0.41 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Operating Expenses | – | – | -$9.00M | – | – |
| – | – | $1.00M | -$15.00M | -$11.00M | |
| Gain on Sale of Security | – | – | – | $51.00M | – |
| -Gain on Sale Of Business | – | – | – | -$22.00M | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | – | $2.00M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $40.04B | $39.86B | $40.04B | $40.75B | $40.75B |
| Total Current Assets | $14.60B | $13.76B | $13.71B | $13.95B | $13.95B |
| Cash and Cash Equivalents & Short-Term Investments | $4.09B | $3.66B | $3.74B | $3.56B | $3.56B |
| -Cash and Cash Equivalents | $4.09B | $3.66B | $3.74B | $3.56B | $3.56B |
| Receivables | $3.84B | $3.49B | $3.39B | $3.71B | $3.71B |
| -Accounts Receivable | $3.84B | $3.49B | $3.39B | $3.71B | $3.71B |
| Prepaid Assets | $1.01B | $1.03B | $1.07B | $1.12B | $1.12B |
| Inventory | $3.17B | $3.22B | $3.18B | $3.18B | $3.18B |
| Other Current Assets | $657.00M | $563.00M | $536.00M | $538.00M | $538.00M |
| Total Non-Current Assets | $25.44B | $26.10B | $26.33B | $26.80B | $26.80B |
| Net PPE | $4.07B | $4.26B | $4.33B | $4.43B | $4.43B |
| -Gross PPE | $4.07B | $4.26B | $4.33B | $9.15B | $9.15B |
| Goodwill and Other Intangible Assets | $19.05B | $19.29B | $19.43B | $19.78B | $19.78B |
| -Goodwill | $15.74B | $15.84B | $15.82B | $16.00B | $16.00B |
| -Other Intangible Assets | $3.30B | $3.45B | $3.61B | $3.78B | $3.78B |
| Non-Current Deferred Assets | $2.06B | $2.16B | $2.19B | $2.19B | $2.19B |
| Other Non-Current Assets | $269.00M | $387.00M | $377.00M | $405.00M | $405.00M |
| Total Liabilities | $32.06B | $32.10B | $31.81B | $32.83B | $32.83B |
| Total Current Liabilities | $15.43B | $15.65B | $13.53B | $13.46B | $13.46B |
| Payables | $2.55B | $2.72B | $2.60B | $2.53B | $2.53B |
| -Accounts Payable | $2.55B | $2.72B | $2.60B | $2.53B | $2.53B |
| Current Accrued Expenses | $2.96B | $2.74B | $2.62B | $2.69B | $2.69B |
| Short-Term Debt and Capital Lease Obligation | $4.04B | $4.50B | $2.61B | $1.82B | $1.82B |
| -Current Debt | $4.04B | $4.50B | $2.61B | $1.82B | $1.82B |
| Current Provisions | $3.96B | $3.90B | $3.71B | $4.14B | $4.14B |
| Other Current Liabilities | $1.33B | $1.30B | $1.45B | $1.54B | $1.54B |
| Total Non-Current Liabilities | $16.63B | $16.45B | $18.28B | $19.38B | $19.38B |
| Long Term Debt and Capital Lease Obligation | $12.95B | $12.37B | $14.30B | $15.27B | $15.27B |
| -Long Term Debt | $12.68B | $12.09B | $14.02B | $14.99B | $14.99B |
| -Long Term Capital Lease Obligation | $266.00M | $282.00M | $280.00M | $288.00M | $288.00M |
| Non-Current Deferred Liabilities | $263.00M | $289.00M | $273.00M | $296.00M | $296.00M |
| Other Non-Current Liabilities | $3.42B | $3.79B | $3.71B | $3.81B | $3.81B |
| Total Equity | $7.98B | $7.76B | $8.23B | $7.91B | $7.91B |
| Stockholders' Equity | $7.98B | $7.75B | $8.23B | $7.91B | $7.91B |
| Capital Stock | $59.00M | $59.00M | $59.00M | $58.00M | $58.00M |
| -Common Stock | $59.00M | $59.00M | $59.00M | $58.00M | $58.00M |
| Additional Paid-In Capital | $28.31B | $28.26B | $28.20B | $28.13B | $28.13B |
| Retained Earnings | -$13.74B | -$13.97B | -$13.39B | -$13.76B | -$13.76B |
| Less: Treasury Stock | -$4.10B | -$4.13B | -$4.13B | -$4.13B | -$4.13B |
| Gains/Losses Not Affecting Retained Earnings | -$2.56B | -$2.47B | -$2.51B | -$2.39B | -$2.39B |
| Minority Interests | $5.00M | $4.00M | $4.00M | $4.00M | $4.00M |
| -Accumulated Depreciation | – | – | – | -$4.73B | -$4.73B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $241.00M | $411.00M | -$40.00M | $1.65B | $1.16B |
| Net cash flow from continuing operations | $241.00M | $411.00M | -$40.00M | $1.65B | $1.16B |
| Net Income from Continuing Operations | $234.00M | -$575.00M | $369.00M | $1.42B | $481.00M |
| Gain/Loss from Continuing Operations | $155.00M | -$12.00M | -$8.00M | – | – |
| Depreciation & Depletion & Amortization | $245.00M | $241.00M | $239.00M | $1.00B | $260.00M |
| Deferred Tax | $53.00M | $25.00M | -$22.00M | -$671.00M | -$595.00M |
| Other Non-Cash Items | -$30.00M | $743.00M | -$54.00M | $81.00M | -$93.00M |
| Change in Working Capital | -$682.00M | -$164.00M | -$617.00M | -$1.37B | $281.00M |
| Net cash flow from investing | $210.00M | -$491.00M | $229.00M | $737.00M | $165.00M |
| Net Cash Flow from Continuing Investing Activities | $210.00M | -$490.00M | $229.00M | $737.00M | $165.00M |
| Net PPE Purchase and Sale | -$120.00M | -$104.00M | -$168.00M | -$501.00M | -$142.00M |
| Net Intangibles Purchase and Sale | -$46.00M | – | – | – | – |
| Net Business Purchase and Sale | $47.00M | -$692.00M | $42.00M | $34.00M | $0.00 |
| Net Other Investing Changes | $2.00M | -$5.00M | $1.00M | $5.00M | -$1.00M |
| Financing Cash Flow | $6.00M | -$1.00M | $13.00M | -$2.15B | $40.00M |
| Net Cash Flow from Continuing Financing Activities | $5.00M | -$1.00M | $13.00M | -$2.15B | $40.00M |
| Net Issuance Payments Of Debt | -$38.00M | $0.00 | -$23.00M | -$1.81B | $0.00 |
| Net Other Financing Charges | $44.00M | -$1.00M | $36.00M | -$337.00M | $40.00M |
| Ending Cash Balance | $4.09B | $3.66B | $3.74B | $3.56B | $3.56B |
| Net Change in Cash | $457.00M | -$81.00M | $202.00M | $235.00M | $1.36B |
| Beginning Cash Balance | $3.66B | $3.74B | $3.56B | $3.30B | $2.20B |
| Effect of Exchange Rate Changes | -$27.00M | -$5.00M | -$17.00M | $21.00M | -$10.00M |
| Free Cash Flow | $75.00M | $307.00M | -$208.00M | $1.15B | $1.06B |
| Net Investment Purchase and Sale | – | -$1.00M | $0.00 | -$15.00M | $25.00M |
| -Change in Receivables | – | – | – | -$173.00M | – |
| -Change in Inventory | – | – | – | $152.00M | – |
| -Change in Payables and Accrued Expense | – | – | – | -$15.00M | – |
| -Change in Other Current Assets | – | – | – | -$1.33B | – |
No comments yet — be the first to weigh in on TEVA.
Sign in to join the discussion.